Daniel Lieber

Title: Daniel Lieber: Innovator in Cancer Therapeutics

Introduction

Daniel Lieber is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research through his innovative approaches to therapeutic and diagnostic methods. His work focuses on improving treatment outcomes for cancer patients.

Latest Patents

Daniel Lieber holds a patent for "Therapeutic and diagnostic methods for cancer." This invention provides various methods for treating cancer, determining the likelihood of a patient's response to immune checkpoint inhibitors, predicting treatment responsiveness, selecting appropriate therapies, providing prognoses, and monitoring responses based on blood tumor mutational burden (bTMB) scores or maximum somatic allele frequencies (MSAF) from blood samples.

Career Highlights

Throughout his career, Daniel Lieber has worked with leading companies in the biotechnology sector, including Genentech, Inc. and Foundation Medicine, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in cancer treatment.

Collaborations

Daniel has collaborated with notable professionals in the field, including Craig Anthony Cummings and Yan Li. These partnerships have contributed to the advancement of his research and the development of effective cancer therapies.

Conclusion

Daniel Lieber's work in cancer therapeutics exemplifies the impact of innovation in medicine. His patent and collaborations highlight his commitment to improving patient outcomes through advanced diagnostic and treatment methods.